MedImmune Oncology, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MedImmune Oncology, Inc..The latest application filed is for "methods for the administration of amifostine and related compounds".

Company Profile

0.9.11

MedImmune Oncology, Inc. -
Medimmune Oncology, Inc. - Gaithersburg MD
MedImmune Oncology, Inc. - West Conshohocken PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for the administration of amifostine and related compounds App 20080207566 - Cassatt; David ; et al.	2008-08-28
Methods for the administration of amifostine and related compounds Grant 7,368,440 - Cassatt , et al. May 6, 2	2008-05-06
Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds App 20060270636 - Stogniew; Martin ; et al.	2006-11-30
Methods for the treatment of neuro- disorders using aminothiol compounds Grant 7,105,575 - Stogniew , et al. September 12, 2	2006-09-12
Methods for the administration of amifostine and related compounds Grant 7,053,072 - Cassatt , et al. May 30, 2	2006-05-30
Topical administration of amifostine and related compounds App 20050282785 - Stogniew, Martin ; et al.	2005-12-22
Stable amorphous amifostine compositions and methods for the preparation and use of same App 20050209200 - Stogniew, Martin ; et al.	2005-09-22
Stable amorphous amifostine compositions and methods for the preparation of same Grant 6,841,545 - Stogniew , et al. January 11, 2	2005-01-11
Topical administration of amifostine and related compounds Grant 6,753,323 - Stogniew , et al. June 22, 2	2004-06-22
Novel compositions comprising trimetrexate and methods of their synthesis and use App 20030216418 - Stogniew, Martin ; et al.	2003-11-20
Thermally stable trimetrexates and processes for producing the same App 20030199694 - Stogniew, Martin ; et al.	2003-10-23
Topical administration of amifostine and related compounds App 20030022867 - Stogniew, Martin ; et al.	2003-01-30
Pharmaceutical formulations comprising aminoalkyl phosphorothioates Grant 6,489,312 - Stogniew , et al. December 3, 2	2002-12-03
Stable amorphous amifostine compositions and methods for the preparation of same App 20020147180 - Stogniew, Martin ; et al.	2002-10-10
Tremextrexate derivatives and pharmaceutical compositions comprising the same App 20020107393 - Stogniew, Martin ; et al.	2002-08-08
Stable amorphous amifostine compositions and dosage form Grant 6,384,259 - Stogniew , et al. May 7, 2	2002-05-07
Methods for the administration of amifostine and related compounds App 20020035093 - Stogniew, Martin	2002-03-21
Novel compositions comprising trimetrexate App 20010031755 - Stogniew, Martin ; et al.	2001-10-18
Compositions comprising trimetrexate and methods of their synthesis and use Grant 6,258,821 - Stogniew , et al. July 10, 2	2001-07-10
Thermally stable trimetrexates and processes for producing the same Grant 6,258,952 - Stogniew , et al. July 10, 2	2001-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.